5 must-read analyst questions from Celsius’s Q3 2026 earnings call

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CELH Cover Image

Celsius’s latest quarter was met with a positive market reaction, as the company delivered results ahead of Wall Street’s expectations. Management attributed this performance to portfolio strength, particularly a standout quarter from Alani Nu, which benefited from its largest-ever limited-time offer. CEO John Fieldly emphasized the importance of differentiated brands in driving consumer reach, noting, “Our modern energy brands contributed approximately 28% of zero-sugar energy category growth in the third quarter.” The company also highlighted operational discipline and the early impact of revenue growth management initiatives.

Is now the time to buy CELH? Find out in our full research report (it’s free for active Edge members).

Celsius (CELH) Q3 2026 highlights:

  • Revenue $847.2 million vs S&P analyst consensus of $795.5 million (16.8% year-on-year growth, 6.5% beat)
  • Adjusted EPS $0.41 vs S&P analyst consensus of $0.34 (21.6% beat)
  • Adjusted EBITDA $198.6 million vs analyst estimates of $168.6 million (23.4% margin, 17.8% beat)
  • Operating margin 20.3%, up from -11% in the same quarter last year
  • Market capitalization $8.06 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from Celsius’s Q3 earnings call

  • Peter Grom (UBS): asked for expectations around the CELSIUS brand’s trajectory into 2027. CEO John Fieldly described the focus on returning to growth as innovation cycles back and execution sharpens, emphasizing that “the register is the scoreboard.”
  • Bonnie Herzog (Goldman Sachs): inquired about gross margin recovery and pricing strategy. CFO Jarrod Langhans detailed the shift to account-specific pricing and a holistic revenue growth management program rather than broad price increases, with a longer timeline for margin improvement due to commodity headwinds.
  • Kaumil Gajrawala (Jefferies): questioned the impact of shipment timing and inventory cycles on reported results. Langhans clarified how Q3 benefited from shipment pull-forward and outlined the factors influencing Q4 comparability, including inventory movements and integration timing.
  • Gerald Pascarelli (Needham & Company): sought clarity on Alani’s scan versus reported sales divergence. Langhans explained that DSD transition and contract amortization would normalize by Q2 next year, leading to cleaner alignment between scan data and reported sales.
  • Michael Lavery (Piper Sandler): asked about the weight of new product launches like Energy+ Hydration and what’s driving international performance. Fieldly stated that growth is not solely dependent on new launches, with core innovation and international brand momentum both playing substantial roles.

Catalysts in upcoming quarters

In upcoming quarters, our team will be watching (1) the rollout and consumer uptake of new CELSIUS and Alani Nu products, (2) the execution and measurable impact of the company’s portfolio-wide revenue growth management program, and (3) continued international market share gains, particularly in Europe and Australia. Progress on cost savings and integration synergies will also be critical markers for sustainable margin recovery.

Celsius currently trades at $32.11, up from $30.71 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

Our favorite stocks right now

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article